Navigation Links
NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange
Date:12/14/2009

Legislation Critical to Stemming Tide of Tens of Thousands of New Chronic Hepatitis Infections Annually

WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ -- Legislation approved by Congress providing for federal funding of syringe exchange will be crucial in helping to reduce tens of thousands of new viral hepatitis infections occurring each year in the United States, the National Viral Hepatitis Roundtable (NVHR) said today. The provision was included in the FY 2010 Consolidated Appropriations bill approved by the House and Senate this weekend. President Obama is expected to sign the measure shortly.

The NVHR is a coalition of more than 150 public, private, and voluntary organizations dedicated to reducing the incidence of infection, morbidity, and mortality from viral hepatitis in the US through strategic planning, leadership, coordination, advocacy, and research. www.nvhr.org

"NVHR is pleased that Congress has acted on this sensible legislation that will reduce new viral hepatitis infections and ultimately save lives," said NVHR Chair Lorren Sandt. "Syringe exchange is a crucial tool in a comprehensive arsenal of counseling and medical referral programs designed to reduce drug use and infection. NVHR wishes to thank Representative Jose Serrano, Chairman David Obey, and thousands of activists for their tireless efforts in helping to address this critical public health issue."

An estimated 5.4 million Americans are infected with chronic viral hepatitis B and C and the majority are unaware they are infected. Injection drug use with shared syringes or equipment is the leading cause of hepatitis C, and 70 percent of people who inject drugs are infected. If left untreated, hepatitis B and C can cause serious liver disease, including cirrhosis, liver cancer, and liver failure. Needle exchange programs are an essential strategy to prevent the spread of hepatitis B and C infection, and provide vital counseling, testing, education, hepatitis A and B vaccine, and referral to medical care. According to the respected research firm Milliman, the cost of chronic hepatitis C virus infection alone could reach $85 billion annually by 2024, with Medicare and Medicaid absorbing a disproportionate share of those costs.

In early January 2010, the Institute of Medicine (IoM) is expected to release a report on viral hepatitis in the United States that outlines strategies for reducing the incidence of viral hepatitis infection and addressing medical complications in those individuals with chronic infections.

SOURCE National Viral Hepatitis Roundtable


'/>"/>
SOURCE National Viral Hepatitis Roundtable
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SNM applauds FDAs issuing of new drug manufacturing requirements
2. Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts
3. Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health
4. Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform
5. Wounded Warrior Project (WWP) Applauds the Senate for Passing Crucial Family Caregiver Legislation
6. Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS
7. American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill
8. APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill
9. National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009
10. NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform
11. National Alliance for Hispanic Health Applauds Confirmation of Dr. Regina Benjamin as the 18th Surgeon General of the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: